Literature DB >> 21813489

Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.

Mark Weiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21813489     DOI： 10.1176/appi.ajp.2011.11050765

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Integrating Genomics into Psychiatric Practice: Ethical and Legal Challenges for Clinicians.

Authors:  Eric T Ward; Kristin M Kostick; Gabriel Lázaro-Muñoz
Journal:  Harv Rev Psychiatry       Date:  2019 Jan/Feb       Impact factor: 3.732

2.  Is pharmacological intervention necessary in prodromal schizophrenia?

Authors:  Jingping Zhao; Hailong Lv; Xiaofeng Guo
Journal:  Shanghai Arch Psychiatry       Date:  2012-12

3.  Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study.

Authors:  Frauke Schultze-Lutter; Chantal Michel; Stephan Ruhrmann; Benno G Schimmelmann
Journal:  Schizophr Bull       Date:  2013-12-18       Impact factor: 9.306

4.  Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: a voxel-based structural MRI study.

Authors:  Kazue Nakamura; Tsutomu Takahashi; Kiyotaka Nemoto; Atsushi Furuichi; Shimako Nishiyama; Yumiko Nakamura; Eiji Ikeda; Mikio Kido; Kyo Noguchi; Hikaru Seto; Michio Suzuki
Journal:  Front Psychiatry       Date:  2013-03-18       Impact factor: 4.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.